{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:35:27Z","timestamp":1779291327675,"version":"3.51.4"},"update-to":[{"DOI":"10.1016\/j.biopha.2016.06.007","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81260505"],"award-info":[{"award-number":["81260505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2013GXNSFAA019150"],"award-info":[{"award-number":["2013GXNSFAA019150"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2014GXNSFAA118154"],"award-info":[{"award-number":["2014GXNSFAA118154"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.biopha.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T17:50:49Z","timestamp":1465840249000},"page":"669-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["RETRACTED: Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis"],"prefix":"10.1016","volume":"82","author":[{"given":"Quanfang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongpeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.06.007_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annual review of pathology: mechanisms of disease"},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/egh.11.92","article-title":"Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques","volume":"6","author":"Tacke","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jss.2014.03.036","article-title":"Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis","volume":"190","author":"Bohanon","year":"2014","journal-title":"J. Surg. Res."},{"issue":"7","key":"10.1016\/j.biopha.2016.06.007_bib0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jgh.12147","article-title":"Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-\u03baB pathway in activated stellate cells: in vivo and in vitro studies","volume":"28","author":"Kong","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0025","doi-asserted-by":"crossref","first-page":"G18","DOI":"10.1152\/ajpgi.00336.2003","article-title":"Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells","volume":"287","author":"Marra","year":"2004","journal-title":"Am. J. Physiol.-Gastrointestinal Liver Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2016.06.007_bib0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/jmbi.2001.4784","article-title":"Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein","volume":"310","author":"Serre","year":"2001","journal-title":"J. Mol. Biol."},{"issue":"6749","key":"10.1016\/j.biopha.2016.06.007_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/43686","article-title":"Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP","volume":"401","author":"Yeung","year":"1999","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.biopha.2016.06.007_bib0040","doi-asserted-by":"crossref","first-page":"23407","DOI":"10.1074\/jbc.M112.363812","article-title":"Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2","volume":"287","author":"Deiss","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.biopha.2016.06.007_bib0045","doi-asserted-by":"crossref","first-page":"33377","DOI":"10.1074\/jbc.M112.367656","article-title":"Raf-1 kinase inhibitory protein (RKIP) mediates ethanol-induced sensitization of secretagogue signaling in pancreatic acinar cells","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/or.2013.2464","article-title":"Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression","volume":"30","author":"Zhao","year":"2013","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2016.06.007_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004180050447","article-title":"In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor \u03b22 and ascorbic acid 2-phosphate","volume":"112","author":"Tullberg-Reinert","year":"1999","journal-title":"Histochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2016.06.007_bib0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/PL00000209","article-title":"Comparative quantification of IL-1\u03b2, IL-10, IL-10r, TNF\u03b1 and IL-7 mRNA levels in UV-irradiated human skin in vivo","volume":"49","author":"Brink","year":"2000","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.biopha.2016.06.007_bib0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2005.07.007","article-title":"A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration","volume":"12","author":"Zhu","year":"2005","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2016.06.007_bib0070","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.fct.2012.07.053","article-title":"Methyl helicterate protects against CCl 4-induced liver injury in rats by inhibiting oxidative stress, NF-\u03baB activation, Fas\/FasL pathway and cytochrome P4502E1 level","volume":"50","author":"Lin","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2016.06.007_bib0075","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.3892\/mmr.2015.4069","article-title":"Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70","volume":"12","author":"He","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2016.06.007_bib0080","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.intimp.2015.06.021","article-title":"Gypsophila elegans isoorientin attenuates CCl4-induced hepatic fibrosis in rats via modulation of NF-kappaB and TGF-beta1\/Smad signaling pathways","volume":"28","author":"Lin","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2016.06.007_bib0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/1541-7786.MCR-08-0403","article-title":"Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer","volume":"7","author":"Li","year":"2009","journal-title":"Molecular cancer research: MCR"},{"issue":"2","key":"10.1016\/j.biopha.2016.06.007_bib0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10620-012-2341-y","article-title":"RKIP and 14-3-3\u03b5 exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK\/MAPK pathway differently","volume":"58","author":"Yan","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2016.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bcp.2004.04.024","article-title":"The role of Raf kinase inhibitor protein (RKIP) in health and disease","volume":"68","author":"Keller","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2016.06.007_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.cad.0000136877.89057.b9","article-title":"Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP)","volume":"15","author":"Keller","year":"2004","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.biopha.2016.06.007_bib0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.06.189","article-title":"Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury","volume":"361","author":"Antoine","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2016.06.007_bib0115","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.01.007","article-title":"Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor","volume":"128","author":"Svegliati-Baroni","year":"2005","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.biopha.2016.06.007_bib0120","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.onc.1210860","article-title":"Snail is a repressor of RKIP transcription in metastatic prostate cancer cells","volume":"27","author":"Beach","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0125","article-title":"Viral infection and cancer: the NF-\u03baB\/Snail\/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes","volume":"30","author":"Baritaki","year":"2010","journal-title":"Critic.Rev.\u2122 Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2016.06.007_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2008.04.072","article-title":"Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer","volume":"72","author":"Ignatoski","year":"2008","journal-title":"J. Radiat. Oncol. Biol. Phys."},{"issue":"17","key":"10.1016\/j.biopha.2016.06.007_bib0135","doi-asserted-by":"crossref","first-page":"17515","DOI":"10.1074\/jbc.M313816200","article-title":"RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis","volume":"279","author":"Chatterjee","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2016.06.007_bib0140","first-page":"528","article-title":"Differential expression of matrix-metalloproteinase-1 and \u22122 genes in normal and fibrotic human liver","volume":"144","author":"Milani","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2016.06.007_bib0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.510300432","article-title":"Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions","volume":"30","author":"Pr\u00e9aux","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2016.06.007_bib0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9440(10)65636-2","article-title":"Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers","volume":"153","author":"Th\u00e9ret","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2016.06.007_bib0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells","author":"Benyon","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2016.06.007_bib0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.510300431","article-title":"Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation","volume":"30","author":"Benyon","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2016.06.007_bib0165","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.20683","article-title":"Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism","volume":"41","author":"Galli","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2016.06.007_bib0170","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/labinvest.3700094","article-title":"Dominant-negative soluble PDGF-\u03b2 receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis","volume":"84","author":"Borkham-Kamphorst","year":"2004","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.biopha.2016.06.007_bib0175","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","article-title":"Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein","volume":"20","author":"Yeung","year":"2000","journal-title":"Mol. Cell. Biol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2016.06.007","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}},{"DOI":"10.1016\/j.biopha.2026.119464","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000}},{"DOI":"10.1016\/j.biopha.2026.119464","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216304681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216304681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:06:48Z","timestamp":1777882008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216304681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":35,"alternative-id":["S0753332216304681"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.06.007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}